Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3523679012 | Product containing certolizumab pegol (medicinal product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
3713866015 | Certolizumab pegol-containing product | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing certolizumab pegol | Is a | Inflammatory bowel disease drug | false | Inferred relationship | Existential restriction modifier | ||
Product containing certolizumab pegol | Is a | Product containing monoclonal antibody | true | Inferred relationship | Existential restriction modifier | ||
Product containing certolizumab pegol | Has active ingredient | Certolizumab pegol | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing certolizumab pegol | Is a | Product containing tumor necrosis factor alpha inhibitor | true | Inferred relationship | Existential restriction modifier | ||
Product containing certolizumab pegol | Is a | Virtual therapeutic moiety | false | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets